Development of the Novel TNF Inhibitor Nanozora<sup>Ⓡ</sup>

Authors

Institutions

Publication Details

Journal
Drug Delivery System
Published
2025-03-25
DOI
https://doi.org/10.2745/dds.40.151
Primary Topic
Nanoplatforms for cancer theranostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of the Novel TNF Inhibitor NanozoraⓇ

Masafumi Kawanishi, Yasuyuki Fujii, Takayuki Sato, Kenji Hachiuma et al.
Drug Delivery System
Nanoplatforms for cancer theranostics
article

Development of the Novel TNF Inhibitor NanozoraⓇ

Masafumi Kawanishi, Yasuyuki Fujii, Takayuki Sato, Kenji Hachiuma, Tomofumi Kurokawa
article en

Abstract

No abstract available for this paper.
Drug Delivery SystemVol. 40(2)
Taisho Pharmaceutical (Japan) (JP)
Openalex Percentile: Top 86%
Nanoplatforms for cancer theranostics
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Development of the Novel TNF Inhibitor Nanozora<sup>Ⓡ</sup> — Masafumi Kawanishi, Yasuyuki Fujii, et al. · Drug Delivery System (2025) | TGRS Research Map | TGRS